Drug Trial Radar · NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Jan 29, 2020
Primary completion
Feb 1, 2028
Study completion Feb 1, 2028
Sponsor
- Lead sponsor
- Incyte Biosciences International SàrlIncyte (INCY)
- Sponsor type
- Industry
- First posted
- May 1, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 year, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ponatinib in children aged 1 to \< 18 years with advanced leukemias, lymphomas, and solid tumors.
Conditions
- Acute Myeloid Leukemia
- Accelerated Phase Chronic Myeloid Leukemia
- Blast Phase Chronic Myeloid Leukemia
- Chronic Phase Chronic Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Acute Lymphocytic Leukemia
- Leukemia
- Lymphoma
- Solid Tumors
Interventions
PonatinibDrug
Ponatinib administered as a tablet or age-appropriate formulation for pediatric participants according to age-based cohort assignment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1: Number of dose-limiting toxicitiesTime frame: 28 days
- Phase 2: Efficacy of ponatinib assessed by major cytogenetic response (MCyR) in participants with chronic-phase chronic myeloid leukemia (CP-CML)Time frame: 12 months
- Phase 2: Efficacy of ponatinib assessed by major hematologic response (MaHR) or major molecular response (MMR) in participants with BCR-ABL-positive leukemiasTime frame: 3 months
- Phase 2: Efficacy of ponatinib assessed by complete response (CR) in participants with leukemias other than BCR-ABL-positive leukemias to determine the efficacy of ponatinibTime frame: 6 months
- Phase 2: Efficacy of ponatinib assessed by incomplete complete response (iCR) in participants with leukemias other than BCR-ABL-positive leukemiasTime frame: 6 months
- Phase 2: Efficacy of ponatinib assessed by CR in participants with lymphomaTime frame: 6 months
- Phase 2: Efficacy of ponatinib assessed by overall response rate in participants with solid tumorsTime frame: 6 months
Locations
23 sites in 7 countries. Site status is shown where the registry gives one.
Ghent University Hospital
Ghent, Belgium · Recruiting
Hopital Robert Debre
Paris, France · Recruiting
Armand Trousseau Hospital
Paris, France · Recruiting
Centre Hospitalier Universitaire de Poitiers
Poitiers, France · Recruiting
Chu de Rennes - Hospital Sud
Rennes, France · Completed
Aou Policlinico S. Orsola-Malpighi
Bologna, Italy · Recruiting
Asst Degli Spedali Civili Di Brescia
Brescia, Italy · Recruiting
Ospedale Pediatrico G. Gaslini
Genova, Italy · Recruiting
Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano
Milan, Italy · Recruiting
University of Milano Bicocca
Monza, Italy · Recruiting
Aorn Santobono Pausilipon
Naples, Italy · Recruiting
Comitato Di Bioetica Della Fondazione Irccs Policlinico San Matteo
Pavia, Italy · Recruiting
Ospedale Pediatrico Bambino Gesu Irccs
Rome, Italy · Recruiting
A.O.U Citta Della Salute E Della Scienza Di Torino Presidio Ospedaliero Infantile Regina Margherita
Torino, Italy · Recruiting
Princess Maxima Center For Pediatric Oncology
Utrecht, Netherlands · Recruiting
Hospital General Universitario Vall D Hebron
Barcelona, Spain · Recruiting
Hospital Sant Joan de Deu de Manresa
Barcelona, Spain · Recruiting
Hospital Infantil Unversitario Nino Jesus
Madrid, Spain · Recruiting
Hospital Universitari I Politecnic La Fe
Valencia, Spain · Recruiting
Karolinska University Hospital Solna
Stockholm, Sweden · Recruiting
Royal Hospital For Sick Children Yorkhill Glasgow
Glasgow, United Kingdom · Recruiting
Alder Hey Childrens Nhs Foundation Trust
Liverpool, United Kingdom · Recruiting
The Royal Marsden Nhs Foundation Trust - Sutton
Sutton, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.